HDAC Inhibition Suppresses Primary Immune Responses, Enhances Secondary Immune Responses, and Abrogates Autoimmunity During Tumor Immunotherapy

Histone deacetylase inhibitors (HDACi) can modulate innate antiviral responses and render tumors more susceptible to oncolytic viruses (OVs); however, their effects on adaptive immunity in this context are largely unknown. Our present study reveals an unexpected property of the HDACi MS-275 that enh...

Full description

Saved in:
Bibliographic Details
Main Authors: Bridle, Byram W, Chen, Lan, Lemay, Chantal G, Diallo, Jean-Simon, Pol, Jonathan, Nguyen, Andrew, Capretta, Alfredo, He, Rongqiao, Bramson, Jonathan L, Bell, John C, Lichty, Brian D, Wan, Yonghong
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2013
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3616544/
https://ncbi.nlm.nih.gov/pubmed/23295947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2012.265
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items